Sun Pharma Advanced Research Company Limited (BOM:532872)
India · Delayed Price · Currency is INR 197.60
+0.85 (0.43%)
At close: Oct 7, 2026
BOM:532872 Market Cap
BOM:532872 has a market cap or net worth of 64.17 billion as of October 7, 2026. Its market cap has increased by 49.91% in one year.
Market Cap
64.17B
Enterprise Value
69.75B
Revenue
19.09B
Global Rank
n/a
Country Rank
n/a
PE Ratio
4.03
ChartMarket Cap Chart
Since July 18, 2007, BOM:532872's market cap has increased from 17.19B to 64.17B, an increase of 273.37%. That is a compound annual growth rate of 7.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 64.17B | 47.07% |
| Dec 31, 2025 | 43.63B | -32.96% |
| Dec 31, 2024 | 65.08B | -30.07% |
| Dec 29, 2023 | 93.07B | 62.05% |
| Dec 30, 2022 | 57.43B | -24.01% |
| Dec 31, 2021 | 75.58B | 48.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 101.91B |
| Procter & Gamble Health | 88.01B |
| Morepen Laboratories | 78.77B |
| Bliss GVS Pharma | 71.25B |
| Sanofi India | 70.27B |
| FDC Limited | 54.42B |
| Evonile Pharma | 50.59B |
| Gufic Biosciences | 42.89B |